These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2256066)

  • 1. [Consequences of changing from fixed amount payments to percentage payment of drugs].
    Berg SH; Aasmundstveit O; Saanum DT
    Tidsskr Nor Laegeforen; 1990 Oct; 110(26):3391-4. PubMed ID: 2256066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.
    Soumerai SB; Avorn J; Ross-Degnan D; Gortmaker S
    N Engl J Med; 1987 Aug; 317(9):550-6. PubMed ID: 3302713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of copayments on drug use in the presence of annual payment limits.
    Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical insurance and the demand for prescription pharmaceuticals in Västerbotten, Sweden.
    Rudholm N
    Scand J Public Health; 2005; 33(1):50-6. PubMed ID: 15764241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs of care in uremia. How much does kidney transplantation cost?].
    Jakobsen A; Albrechtsen D; Sødal G; Flatmark A; Fauchald P; Vartdal F
    Tidsskr Nor Laegeforen; 1990 Jan; 110(3):338-41. PubMed ID: 2309175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copayment for pharmaceutical services in a Medicaid program.
    Nelson AA; Quick MR
    Contemp Pharm Pract; 1980; 3(1):37-42. PubMed ID: 10297666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer response to dual incentives under multitiered prescription drug formularies.
    Gilman BH; Kautter J
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):353-9. PubMed ID: 17567236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a medication copayment increase in veterans with schizophrenia.
    Zeber JE; Grazier KL; Valenstein M; Blow FC; Lantz PM
    Am J Manag Care; 2007 Jun; 13(6 Pt 2):335-46. PubMed ID: 17567234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical problems associated with the national reference pricing system in Hungary].
    Kerpel-Fronius S
    Orv Hetil; 2004 Apr; 145(17):913-8. PubMed ID: 15170969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of drug reimbursement expenses incurred by National Health Fund in Silesian voivodeship in the period of 1999-2004].
    Swistak P; Dzielicki M; Janiec R; Błońska-Fajfrowska B
    Wiad Lek; 2005; 58(9-10):495-9. PubMed ID: 16529058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of actual cost, DRG-based cost, and hospital reimbursement for liver transplant patients.
    Skeie B; Mishra V; Vaaler S; Amlie E
    Transpl Int; 2002 Oct; 15(9-10):439-45. PubMed ID: 12389074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pricing and reimbursement of pharmaceuticals in Norway.
    Hågå A; Sverre JM
    Eur J Health Econ; 2002; 3(3):215-20. PubMed ID: 15609146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Michigan Medicaid costs to treat HIV infection.
    Solomon DJ; Hogan AJ; Bouknight RR; Solomon CT
    Public Health Rep; 1989; 104(5):416-24. PubMed ID: 2508170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan.
    Chen LC; Schafheutle EI; Noyce PR
    Res Social Adm Pharm; 2009 Sep; 5(3):211-24. PubMed ID: 19733822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Medicaid database to analyze pharmaceutical services in long-term-care facilities.
    Lipowski EE; Wiederholt JB; Kreling DH; Collins TM
    Am J Hosp Pharm; 1986 Jun; 43(6):1467-72. PubMed ID: 3088992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.